Publication in detail

Nat Commun. 2016 May 4;7:11379. doi: 10.1038/ncomms11379.

TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis

Aizawa, S; Okamoto, T; Sugiyama, Y; Kouwaki, T; Ito, A; Suzuki, T; Ono, C; Fukuhara, T; Yamamoto, M; Okochi, M; Hiraga, N; Imamura, M; Chayama, K; Suzuki, R; Shoji, I; Moriishi, K; Moriya, K; Koike, K; Matsuura, Y

Osaka University, Osaka, 565-0871, Japan. Hiroshima University School of Medicine, Hiroshima 734-8551, Japan. National Institute of Infectious Diseases, Tokyo 162-8640, Japan. Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. University of Yamanashi, Yamanashi 409-3898, Japan. The University of Tokyo, Tokyo 113-8655, Japan.

Abstract:
Signal-peptide peptidase (SPP) is an intramembrane protease that participates in the production of the mature core protein of hepatitis C virus (HCV). Here we show that SPP inhibition reduces the production of infectious HCV particles and pathogenesis. The immature core protein produced in SPP-knockout cells or by treatment with an SPP inhibitor is quickly degraded by the ubiquitin-proteasome pathway. Oral administration of the SPP inhibitor to transgenic mice expressing HCV core protein (CoreTg) reduces the expression of core protein and ameliorates insulin resistance and liver steatosis. Moreover, the haploinsufficiency of SPP in CoreTg has similar effects. TRC8, an E3 ubiquitin ligase, is required for the degradation of the immature core protein. The expression of the HCV core protein alters endoplasmic reticulum (ER) distribution and induces ER stress in SPP/TRC8 double-knockout cells. These data suggest that HCV utilizes SPP cleavage to circumvent the induction of ER stress in host cells.

ยป Online Version

Proven Track Record

The team at Ozgene has over two decades of experience creating customised knockout and knock-in mice for pivotal medical research globally. Over 300 scientific publications are based on research using Ozgene mice.

Go to Publications

Global Client Base

Ozgene generates genetically customised mice for researchers around the world. Ozgene mice can be found in 31 different countries on 5 continents from small academic institutions to multinational pharmaceutical companies.

See Map

Lean Management

Ozgene is applying Lean Management principles to deliver the highest quality services and shortest lead times to our customers. The implementation of Lean Culture has already seen an improvement in our processes and timelines.

Read More